Histogen Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Histogen Inc. reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $5.06 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2018-03-08
- Histogen Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2017 was $5.06, a 5.60% decline from fiscal 2016.
- Histogen Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2016 was $5.36, a 18.54% decline from fiscal 2015.
- Histogen Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2015 was $6.58, a 2.66% decline from fiscal 2014.
- Histogen Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2014 was $6.76, a 562.75% increase from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2017-12-31 | $5.06 10-K · filed 2018-03-08 |
| 2016-12-31 | $5.36 10-K · filed 2017-03-16 |
| 2015-12-31 | $6.58 10-K · filed 2016-03-11 |
| 2014-12-31 | $6.76 10-K · filed 2015-03-13 |
| 2013-12-31 | $1.02 10-K · filed 2014-03-28 |